Stronger science. Stronger results.

Consult with our experts

With over 20 years’ experience as a Preclinical CRO, CBI has a range of stem cell toxicology capabilities and efficacy models suitable for your unique research needs.

  • Discovery toxicology
  • Investigative, custom and specialized studies
  • Systemic and localized toxicity
  • Toxicity assessments for ocular, dermal, otic, and regulatory applications
  • Custom or traditional study designs (GLP or non-GLP)
  • Ocular efficacy
  • Cardiopulmonary, intracardiac administration
  • Diabetic efficacy
  • CNS-brain, spinal cord injury models
  • Oncology models
  • Joint, bone, ligament and cartilage injury models
  • Reproductive efficacy models
  • Bone marrow

Our full service in vivo facility also offers:

  • Full range of species including transgenic models
  • Standard and custom endpoints
  • On-site histopathology
  • Immunohistochemistry
  • Tissue cross reactivity
  • In-house board-certified pathologist
  • Efficient, quality reporting

Extensive experience with

  • Small molecules
  • Biologics
  • Immunotherapy
  • Stem cells
  • Devices and implants
  • Gene therapy

Standards of excellence

  • GLP equipped
  • AAALAC accredited
  • USDA, FDA and OLAW compliant

Consult with our experts

Fill out the form below to learn more about our stem cell capabilities